|
Scientific Research Journal |
|
Menu
|
|
Authors
Call for Papers Submission Guidelines Review Process Scirj Indexing APC Editors Editorial Board Publication Ethics Publications Research Journal Special Issue Thesis Monograph Resources RSS & Feeds Subscribe
Scirj, Volume XIII [2025]
December Issue November Issue October Issue September Issue August Issue July Issue June Issue May Issue April Issue March Issue February Issue January Issue |
Scirj Volume VIII, Issue IV, April 2020 Edition ISSN: 2201-2796 
Randomized Trial of Diabetic Macular Edema Treatment with Fewer Ranibizumab Injections and Focal Laser.
Khalid Hamdi Abstract: Randomized Trial of Diabetic Macular Edema Treatment with fewer Ranibizumab injections and focal laser. IMPORTANCE: Several diabetic patients with macular edema can be helped with fewer ranibizumab injections instead of injection and followed for 24-36 months. focal laser to microaneurysms is not a harmful macular procedure. BACKGROUND: To prove the efficiency of focal laser and fewer ranibizumab injections in improving the visual acuity (ETDRS letters) and reducing the central subfield thickness (CST). Reference this Paper: Randomized Trial of Diabetic Macular Edema Treatment with Fewer Ranibizumab Injections and Focal Laser. by Khalid Hamdi published at: "Scientific Research Journal (Scirj), Volume VIII, Issue IV, April 2020 Edition, Page 8-14 ". Search Terms: MACULA- INJECTION- LASER- RANIBIZUMAB- EDEMA-THICKNESS [Read Research Paper] [Full Screen] |
Archive